Skip to content

13F-HR filed by Sofinnova Investments, Inc.

Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 54 holding rows worth $581,834,000.

Accession
0001144204-18-028628
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 55 entries on the cover page, a total value of $581,834,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $581,834,000 with VALUE read as thousands by filing date, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR2,479,514$162,160,000thousands by filing date
NUCANA PLC67022C106ADR4,666,666$88,293,000thousands by filing date
ObsEva SAH5861P103COM4,749,623$64,096,000thousands by filing date
AUDENTES THERAPEUTICS INC.05070R104Common Stock1,380,303$41,478,000thousands by filing date
MERUS N VN5749R100COM1,961,039$36,338,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM481,270$32,048,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM2,893,221$31,970,000thousands by filing date
NATERA INC COM632307104Stock3,100,560$28,742,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock1,539,480$26,972,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM911,752$20,159,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW3,321,588$9,998,000thousands by filing date
Ocugen43358V109Common2,077,040$5,712,000thousands by filing date
SYNLOGIC INC87166L100COM574,972$5,393,000thousands by filing date
ATYR PHARMA INC002120103COM1,866,126$4,945,000thousands by filing date
EDGE THERAPEUTICS INC279870109COM2,852,711$3,366,000thousands by filing date
CHIASMA INC16706W102COM1,630,221$2,445,000thousands by filing date
ALLERGAN PLCG0177J108SHS9,379$1,578,000thousands by filing date
AURIS MED HLDG AGH0381L104COM781,818$1,251,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM9,126$1,017,000thousands by filing date
Bristol-Myers Squibb Company110122108COM15,033$951,000thousands by filing date
HERON THERAPEUTICS INC427746102COM30,133$832,000thousands by filing date
KADMON HLDGS INC48283N106COM186,774$794,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR21,832$763,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM25,729$696,000thousands by filing date
AIMMUNE THERAPEUTICS INC.00900T107Common Stock20,308$646,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW16,847$605,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A29,383$603,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM30,958$523,000thousands by filing date
ARDELYX INC039697107COM99,166$501,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock1,304$449,000thousands by filing date
OTONOMY INC68906L105COM98,624$414,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS3,637$410,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM16,206$387,000thousands by filing date
DERMIRA INC24983L104COM48,320$386,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM35,379$380,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock8,476$374,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS72,017$369,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK102,974$365,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM148,055$354,000thousands by filing date
MEDICINOVA INC58468P206COM NEW32,875$336,000thousands by filing date
KALA BIO INC COM483119103Stock20,409$323,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM8,688$267,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK71,300$252,000thousands by filing dateput
SPECTRUM PHARMACEUTICALS INC84763A108COM15,000$241,000thousands by filing datecall
ONCOMED PHARMACEUTICALS INC COM68234X102Stock67,033$213,000thousands by filing date
EXELIXIS INC COM30161Q104Stock9,300$206,000thousands by filing datecall
AFFIMED N VN01045108COM110,834$205,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM98,126$203,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM12,640$193,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM12,124$173,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock16,694$155,000thousands by filing date
CALITHERA BIOSCIENCES INC COM NEW13089P101Stock19,928$126,000thousands by filing date
ONCOSEC MED INC68234L207COM NEW66,965$126,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock12,952$52,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-18-028628this filing2018-05-15acceptance time not in the bulk data set